| Health Net Comm & Medi-Cal Plan | Genetic Testing for Skeletal Dysplasia and Rare Bone Disorders | 2024-11-01 |
| Ambetter Health Indiana Clinical | Concert Genetics Oncology: Algorithmic Testing (V1.2025) | 2024-11-01 |
| Ambetter Health Indiana Clinical | Concert Genetics Oncology: Cancer Screening (V1.2025) | 2024-11-01 |
| Ambetter Health Indiana Clinical | Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (V1.2025) | 2024-11-01 |
| Ambetter Health Indiana Clinical | Concert Genetics Oncology: Cytogenetic Testing (V1.2025) | 2024-11-01 |
| Ambetter Health Indiana Clinical | Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (V1.2025) | 2024-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Momelotinib | 2024-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Naldemedine | 2024-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Momelotinib | 2024-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Naldemedine | 2024-11-01 |